The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey
Autor: | Serkan Torun, Enis Kesikbaş, Zerrin Gamsizkan, Attila Önmez, Feyzi Gokosmanoglu, Hakan Cinemre, Şeyma Özdemir |
---|---|
Přispěvatelé: | [Belirlenecek] |
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Adult
Blood Glucose Male medicine.medical_specialty Coronavirus disease 2019 (COVID-19) Turkey SARS-cov 2 Endocrinology Diabetes and Metabolism 030209 endocrinology & metabolism Disease Weight Gain Article 03 medical and health sciences 0302 clinical medicine SF-36 Internal medicine Diabetes mellitus Lockdown medicine Internal Medicine Humans In patient 030212 general & internal medicine Glycemic Aged Retrospective Studies business.industry Diabetes Type 2 Diabetes Mellitus COVID-19 Small sample Outbreak Covid 19 General Medicine Middle Aged medicine.disease Diabetes Mellitus Type 2 Glycemic Index Quarantine Female medicine.symptom business Weight gain Follow-Up Studies |
Zdroj: | Diabetes & Metabolic Syndrome: Clinical Research & Reviews Diabetes & Metabolic Syndrome |
ISSN: | 1871-4021 |
DOI: | 10.1016/j.dsx.2020.10.007 |
Popis: | Background and aims A national lockdown to prevent the spread of coronavirus disease (COVID-19) in Turkey was introduced in March 2020. We think that lockdowns may lead to weight gain and worsening of glycemic parameters in patients with type 2 diabetes mellitus (DM). The purpose of this study was to investigate how type 2 DM patients were affected by the lockdown. Method Type 2 DM patients unable to attend regular follow-ups due to lockdown over a 75-day period between March and June 2020 and who again attended polyclinic follow-up when the lockdown was lifted were included in the study. These patients’ glycemic control and weight status were compared with the pre-lockdown period. In addition, patients’ general habits, and adherence to diet and exercise were evaluated, while their general health was assessed using the Short-Form 36-item survey. Result The research involved 101 type 2 DM patients, 57 men (56.5%) and 44 women (44.5%), with a mean age of 55 ± 13. Patients’ mean pre-lockdown weight was 84.7 ± 16.4 kg, rising to 85.5 ± 16.8 kg post-lockdown, although the increase was not statistically significant (p = 0.781). In terms of glycemic parameters, Hba1c rose from 7.67 ± 1.76 to 8.11 ± 2.48, and fasting glucose from 157.9 (83–645) mg/dl to 163.2 (84–550) mg/dl, none of which were statistically significant (p = 0.253, p = 0.079, respectively). Conclusion In addition to weight gain among type 2 DM patients during the Covid 19 lockdown, statistically insignificant increases were also observed in such glycemic parameters. This was a small sample and further studies with larger sample are needed. Highlights • There was statistically insignificant weight gain in patients with diabetes during the lockdown. • Statistically insignificant worsening in glycemic parameters was observed during the lockdown. • There was worsening of lifestyle parameters during the lockdown. |
Databáze: | OpenAIRE |
Externí odkaz: |